Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • FDA clears Johnson & Johnson’s surgical robot for ‘the next era in surgery’

FDA clears Johnson & Johnson’s surgical robot for ‘the next era in surgery’

July 23, 2026Posted inMedical Technology

The FDA has authorized Johnson & Johnson’s Ottava Robotic Surgical System as the company looks to compete with Intuitive Surgical and Medtronic.

Post navigation

Previous Post
transmissible-cancer-discovered-in-freshwater-fish Transmissible Cancer Discovered in Freshwater Fish
Next Post
Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies

Recent Posts

  • Human Dengue Study Reveals How Preexisting Immunity Shapes Secondary Infections
  • Collaboration and Roadmaps Key to Capsid Accessibility
  • Microbial Dark Matter Could Revive Antibiotics
  • Decentralization, AI, and Gene Editing Are Opportunities for CGT Contractors
  • Crossing the Digital Validation Chasm

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top